Adaptive Biotechnologies Updates IPO Filing – Will Raise Up To $327 Million

Adaptive Biotechnologies Updates IPO Filing – Will Raise Up To $327 Million

Source: 
CP Wire
snippet: 

Adaptive updated their IPO filing on 6/26/19 and raised their potential raise to $327 million from $230 million listed in their original filing. The company currently offers tools for monitoring several cancer types, sequencing immune system components, and aiding drug discovery.